Bellevue Group AG
CIK 1674546 · Holdings on Dec 31, 2025 · First reported Feb 17, 2026
Top ten holdings
Q4 2025- RVMD7.56%
- ARGX7.36%
- IONS7.20%
- VRTX5.85%
- NBIX4.58%
- RNA3.60%
- ISRG3.46%
- SRRK3.39%
- ALNY3.36%
- ABT3.13%
Share classes counted separately49.49%
Portfolio value by quarter
What changed this quarter?
Within preview · weight change- RVMDWeight increased · +2.15 pp5.41% → 7.56%Shares -568.12K (-10.19%)
- KRYSWeight increased · +1.92 pp0.00% → 1.92%Shares +409.01K (+31174.62%)
- VRTXWeight increased · +1.73 pp4.12% → 5.85%Shares +175.31K (+34.66%)
Weight = security value ÷ total reported holdings value. Changes are in percentage points; price moves also affect weights, so they are not trade sizes.
Top 10 holdings 30
USD · B = billion · M = million; expand a row for exact values| # | Security | Value | Weight | Quantity | Weight / quantity change | Activity | |
|---|---|---|---|---|---|---|---|
| 01 | RVMDREVOLUTION MEDICINES INC View history and evidence | $398.71M | 7.56% | 5.01M shares | 5.41% → 7.56%+2.15 pp -568.12K (-10.19%) | Reduced | ↗▾ |
| 02 | ARGXARGENX SE - ADRSPONSORED ADR View history and evidence | $388.40M | 7.36% | 461.85K shares | 8.37% → 7.36%-1.01 pp -84.47K (-15.46%) | Reduced | ↗▾ |
| 03 | IONSIONIS PHARMACEUTICALS INC View history and evidence | $379.90M | 7.20% | 4.80M shares | 8.49% → 7.20%-1.29 pp -1.44M (-23.10%) | Reduced | ↗▾ |
| 04 | VRTXVERTEX PHARMACEUTICALS INC View history and evidence | $308.79M | 5.85% | 681.12K shares | 4.12% → 5.85%+1.73 pp +175.31K (+34.66%) | Added | ↗▾ |
| 05 | NBIXNEUROCRINE BIOSCIENCES INC View history and evidence | $241.58M | 4.58% | 1.70M shares | 5.14% → 4.58%-0.56 pp -59.80K (-3.39%) | Reduced | ↗▾ |
| 06 | RNAAVIDITY BIOSCIENCES INC View history and evidence | $189.77M | 3.60% | 2.63M shares | 1.95% → 3.60%+1.65 pp +478.11K (+22.21%) | Added | ↗▾ |
| 07 | ISRGINTUITIVE SURGICAL INCCOM NEW View history and evidence | $182.38M | 3.46% | 322.03K shares | 3.24% → 3.46%+0.22 pp -26.60K (-7.63%) | Reduced | ↗▾ |
| 08 | SRRKSCHOLAR ROCK HOLDING CORP View history and evidence | $178.69M | 3.39% | 4.06M shares | 2.51% → 3.39%+0.88 pp +812.05K (+25.03%) | Added | ↗▾ |
| 09 | ALNYALNYLAM PHARMACEUTICALS INC View history and evidence | $177.31M | 3.36% | 445.90K shares | 4.23% → 3.36%-0.87 pp -621 (-0.14%) | Reduced | ↗▾ |
| 10 | ABTABBOTT LABORATORIES View history and evidence | $165.00M | 3.13% | 1.32M shares | 4.11% → 3.13%-0.98 pp -161.65K (-10.93%) | Reduced | ↗▾ |
Options overlay 0
No options reported this quarter.
Exited positions 9
| Security | Type | Shares out | Value out | Previous filing | This filing |
|---|---|---|---|---|---|
| AGIO AGIOS PHARMACEUTICALS INC | Non-derivative | -3,714,736 | -$149.11M | SEC filing ↗ | SEC filing ↗ |
| AKRO AKERO THERAPEUTICS INC | Non-derivative | -2,389,314 | -$113.44M | SEC filing ↗ | SEC filing ↗ |
| BHVN BIOHAVEN LTD | Non-derivative | -2,802,853 | -$42.07M | SEC filing ↗ | SEC filing ↗ |
3 / 9 preview exits. Up to 30 exit records are previewed. Exit means absent from the current filing; execution date, price and proceeds are unknown.
Every number has a source.
CIK 1674546 · Period 2025-12-31
Data loaded 2026-09-23 · First reported 2026-02-17
Amendments and versions
{
"amendments_merged": null,
"prior_versions": null,
"cover_table_value": 5276933294
}Research all 176 reported holdings.
This page includes 30 of 176 reported holdings. Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.
- Download CSV
- Earlier quarters
- Advanced screening & filtering
- API & AI access
＋ New accounts get free API credits to explore data beyond ownership filings.
For AI agents & developers
The initial HTML of this page carries its exact data as script#portfolio-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account. This page lists 30 of 176 current positions (options included); totals and weights use the complete filing.
Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.
MCP https://api.akkrudata.ai/mcp
get_institutional_portfolio
{"cik":"1674546","quarter":"2025Q4","page_size":100}
get_institutional_manager_history
{"cik":"1674546","page_size":100}Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.
- MCP endpoint
- https://api.akkrudata.ai/mcp
- API / MCP documentation
- /documents
- llms.txt
- /llms.txt
Sources, coverage & how to read this data
Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.